Complementary medicines are widely used and often perceived as safe, yet high doses, product stacking, and unclear labelling can quietly increase the risk of harm.
07 April 2026
An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.
30 March 2026
Two new films document UMC's collaboration with Brazil's Anvisa, exploring how VigiFlow and WHODrug are strengthening pharmacovigilance across the country.
19 March 2026
The 20-year journey of the PAHO Pharmacovigilance Network: from shared learning to coordinated action.
07 May 2026
Brazil’s largest immunobiologicals producer shares lessons from integrating WHODrug Global into its clinical and pharmacovigilance workflows at a national scale.
23 April 2026
A Mexican cardiology hospital became the first to establish a dedicated technovigilance centre in a clinical setting, and its work is already contributing to patient safety.
16 April 2026
Complementary medicines are widely used and often perceived as safe, yet high doses, product stacking, and unclear labelling can quietly increase the risk of harm.
07 April 2026
17 October 2023
01 April 2026
29 January 2026
26 November 2025
22 October 2025
04 September 2025
25 June 2025
04 June 2025
03 April 2025
13 February 2025
13 February 2025
29 October 2024
07 October 2024
26 August 2024
02 May 2024
04 March 2024
05 February 2024
21 December 2023
14 November 2023
07 November 2023
12 October 2023
12 January 2023
02 October 2023
07 September 2023
30 June 2023
10 May 2023
31 March 2023
23 February 2023
31 January 2023
14 November 2022
15 December 2022
03 October 2022
08 March 2022
04 February 2022
25 August 2022
17 June 2021
30 March 2021
08 June 2020
23 May 2018
23 May 2018